Alzheimer Europe organises a Company Round Table meeting in Brussels


On 27 September 2022, Alzheimer Europe hosted a Company Round Table meeting in Brussels. The meeting was a hybrid event, with many participants attending in person and some joining remotely. It was attended by a total of 42 delegates, including 13 company representatives (from Eisai, Essity, GE Healthcare, Grifols, Lill, Roche and TauRx), 8 members of the Alzheimer Europe staff, Alzheimer Europe Chairperson Iva Holmerová, who hosted the meeting, members of the Alzheimer Europe Board and representatives from 16 member organisations of Alzheimer Europe. During the meeting, four speakers provided updates on recent policy and research developments. Cindy Birck, Project Officer, gave an update on our Clinical Trials Watch, while Owen Miller, Policy Officer, shared some recent Policy developments at WHO and EU level.

Next, Jean Georges, Executive Director, informed participants about Alzheimer Europe’s activities in 2022 and 2023, including 2023 sponsorship opportunities. The final two presentations of the meeting came from Anders Gustavsson of PAVE (Project Alzheimer’s Value Europe) and Oana Scarlatescu with Audrey Wolf (EFPIA). Anders provided an overview of a recent PAVE initiative to estimate the numbers of people on the Alzheimer’s disease spectrum, while Oana and Audrey spoke about developing medicines for high unmet needs, and how this is reflected in the new EU pharmaceutical legislation. We would like to thank our sponsors and members for participating in this meeting and we look forward to welcoming them to the next Company Round Table meeting, in December.